Ekso bionics reports certain preliminary fourth quarter and full year 2023 financial results

San rafael, calif., jan. 04, 2024 (globe newswire) -- ekso bionics holdings, inc. (nasdaq: ekso) (the “company”), an industry leader in exoskeleton technology for medical and industrial use, today announced preliminary top line financial results for the fourth quarter and fiscal year ended december 31, 2023.
EKSO Ratings Summary
EKSO Quant Ranking